Lataa...
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
AIMS: To assess the safety and efficacy of monotherapy with once‐weekly subcutaneous (s.c.) semaglutide vs sitagliptin in Japanese people with type 2 diabetes (T2D). METHODS: In this phase IIIa randomized, open‐label, parallel‐group, active‐controlled, multicentre trial, Japanese adults with T2D tre...
Tallennettuna:
| Julkaisussa: | Diabetes Obes Metab |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813234/ https://ncbi.nlm.nih.gov/pubmed/28786547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13082 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|